Oxymetholone is an androgen and anabolic steroid (AAS) medication which is used primarily in the treatment of anemia. It is also used to treat osteoporosis, HIV/AIDS wasting syndrome, and to promote weight gain and muscle growth in certain situations. It is taken by mouth.
Fluoxymesterone is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, breast cancer in women, and anemia. It is taken by mouth.
Side effects of fluoxymesterone include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. It can also cause liver damage and cardiovascular side effects like high blood pressure. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong androgenic effects and moderate anabolic effects, which make it useful for producing masculinization.
Drostanolone enanthate is an androgen and anabolic steroid (AAS) drug used to treat breast cancer in women but is no longer marketed. It is given by intramuscular injection.
Drostanolone enanthate is not orally active and must be administered by intramuscular injection. The elimination half-life of the drug by this route is approximately 8 days. It has a much longer elimination half-life by intramuscular injection than drostanolone. Drostanolone propionate is metabolized to the active form, drostanolone.
Boldenate 250 or boldenone undecenoate is an androgen and anabolic steroid (AAS) drug used in veterinary medicine, particularly in horses. It is given by intramuscular injection.
Boldenone undecylenate is a prodrug of boldenone. When administered by intramuscular injection, a depot is formed where boldenone undecylenate is slowly released into the body and subsequently converted to boldenone. The drug has a biological half-life of 14 days when administered by intramuscular injection.
Testosteron Sustanon, bir androjen ve anabolik steroid ilacı ve karışık testosteron ester preparatlarının bir bileşeni olarak kullanılan bir testosteron esteridir.
Different testosterone esters provide different elimination half-lives in the body. Esterification of testosterone produces a sustained but non-linear release of the hormone testosterone from the injection depot into the circulation.
Clenoxin is a compound that belongs to a class of drugs called beta2-agonists. Beta2-agonists are often used to treat asthma.
Unless recommended otherwise by doctors, the recommended dose is consumed with a glass of water per day according to body weight ratio. Generally, the effective dose is 1-2 mg per body weight per day. The dose of use should be regulated with the advice of a doctor.
The usage period may vary between three and six months, depending on the person's health status.
Testosteron Enanthate, esas olarak erkeklerde düşük testosteron düzeylerinin tedavisinde kullanılan androjen ve anabolik steroid bir ilaçtır. Ayrıca transseksüel erkekler için hormon tedavisinde de kullanılır.
Testosterone enanthate has an elimination half-life of 4.5 days and a mean residence time of 8.5 days when used as a depot intramuscular injection. It requires frequent administration approximately once a week, and with it large fluctuations in testosterone levels occur, the levels initially rise and become above physiological.
Trenbolone hexahydrobenzylcarbonate or trenbolone cyclohexylmethylcarbonate is a synthetic injectable anabolic-androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone.
Trenbolone hexahydrobenzylcarbonate has an activated elimination half-life of about 14 days, of about 14 days.
Trenbolone acetate is an androgen and anabolic steroid drug used in veterinary medicine, specifically to increase livestock profitability by promoting muscle growth in cattle. It is given by intramuscular injection.
The acetate ester of trenbolone acetate provides slow release after injection. This ester gives trenbolone an activated elimination half-life of approximately 3 days.